Literature DB >> 33669762

Prevalence and Associated Factors of Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.

Raquel Cadenas1, María José Diez1, Nélida Fernández1, Juan José García1, Ana M Sahagún1, Matilde Sierra1, Cristina López1, Julen Susperregui2, Raquel Díez1.   

Abstract

In Spain, there has been a progressive increase in aging. Specifically, Leon has been one of the Spanish provinces with the highest aging index. Polypharmacy is highly prevalent among the elderly, with significant consequences for safety. The aim of this study was to assess the consumption of drugs in a nursing home in the province of Leon and establish the relationship between polypharmacy and the most common comorbid diseases. A descriptive, observational, and cross-sectional study design was used. Residents' information and treatments were collected by reviewing on medical charts, completed with clinical information obtained from the physician of the nursing home. The mean age of residents was 86.8 years, and 63.8% were female. Mean medical consumption amounted to 7.02 prescriptions. Polypharmacy was observed in 54.9% of residents, and excessive polypharmacy in 22.1%. The most commonly used medications (ATC classification) were those acting on the cardiovascular system (84.4%) and the nervous system (82.8%). A high-level of drug consumption was observed in the nursing home. Interventions should focus on those residents hospitalized the last year and with recent contact with a general practitioner. There is a need to develop a comprehensive monitoring system to assess the quality of prescriptions for nursing home residents.

Entities:  

Keywords:  aging; elderly; medication; nursing home; polypharmacy; public health

Year:  2021        PMID: 33669762      PMCID: PMC7922018          DOI: 10.3390/ijerph18042037

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  47 in total

1.  Polypharmacy in nursing home in Europe: results from the SHELTER study.

Authors:  Graziano Onder; Rosa Liperoti; Daniela Fialova; Eva Topinkova; Matteo Tosato; Paola Danese; Pietro Folino Gallo; Iain Carpenter; Harriet Finne-Soveri; Jacob Gindin; Roberto Bernabei; Francesco Landi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

3.  Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010.

Authors:  Christina J Charlesworth; Ellen Smit; David S H Lee; Fatimah Alramadhan; Michelle C Odden
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-03-01       Impact factor: 6.053

4.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

5.  Use of potentially inappropriate medications by the elderly at home.

Authors:  Lázara Montezano Lopes; Tácita Pires de Figueiredo; Soraya Coelho Costa; Adriano Max Moreira Reis
Journal:  Cien Saude Colet       Date:  2016-11

6.  [Factors related to polypharmacy in the non-institutionalised elderly. Analysis of the subsample of the national survey of health 2006 for the elderly in Castile-Leon].

Authors:  Elisa Frutos Bernal; Juan Carlos Martín Corral; Purificación Galindo Villardón
Journal:  Rev Esp Geriatr Gerontol       Date:  2011-05-23

7.  Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.

Authors:  Elizabeth D Kantor; Colin D Rehm; Jennifer S Haas; Andrew T Chan; Edward L Giovannucci
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

8.  Frequency of medication errors in primary care patients with polypharmacy.

Authors:  Dara Koper; Gustav Kamenski; Maria Flamm; Birgit Böhmdorfer; Andreas Sönnichsen
Journal:  Fam Pract       Date:  2012-11-06       Impact factor: 2.267

9.  Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study.

Authors:  Julien Castioni; Pedro Marques-Vidal; Nazanin Abolhassani; Peter Vollenweider; Gérard Waeber
Journal:  BMC Health Serv Res       Date:  2017-12-21       Impact factor: 2.655

10.  Factors associated with excessive polypharmacy in older people.

Authors:  Denise Walckiers; Johan Van der Heyden; Jean Tafforeau
Journal:  Arch Public Health       Date:  2015-11-09
View more
  3 in total

1.  Potentially Inappropriate Medication and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.

Authors:  Raquel Díez; Raquel Cadenas; Julen Susperregui; Ana M Sahagún; Nélida Fernández; Juan J García; Matilde Sierra; Cristina López
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

2.  Drug-Related Problems and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.

Authors:  Raquel Díez; Raquel Cadenas; Julen Susperregui; Ana M Sahagún; Nélida Fernández; Juan J García; Matilde Sierra; Cristina López
Journal:  Int J Environ Res Public Health       Date:  2022-04-04       Impact factor: 3.390

3.  Polypharmacy and potential drug-drug interactions among Greenland's care home residents.

Authors:  Nadja Albertsen; Tine Gjedde Sommer; Thomas Mikkel Olsen; Anna Prischl; Hans Kallerup; Stig Andersen
Journal:  Ther Adv Drug Saf       Date:  2022-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.